Home > Publications Database > Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy. > print |
001 | 259687 | ||
005 | 20231120155352.0 | ||
024 | 7 | _ | |a 10.3390/biom13071108 |2 doi |
024 | 7 | _ | |a pmid:37509144 |2 pmid |
024 | 7 | _ | |a pmc:PMC10377647 |2 pmc |
037 | _ | _ | |a DZNE-2023-00759 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Dowling, Paul |b 0 |
245 | _ | _ | |a Extracellular Matrix Proteomics: The mdx-4cv Mouse Diaphragm as a Surrogate for Studying Myofibrosis in Dystrophinopathy. |
260 | _ | _ | |a Basel |c 2023 |b MDPI |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1692713550_2158 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a The progressive degeneration of the skeletal musculature in Duchenne muscular dystrophy is accompanied by reactive myofibrosis, fat substitution, and chronic inflammation. Fibrotic changes and reduced tissue elasticity correlate with the loss in motor function in this X-chromosomal disorder. Thus, although dystrophinopathies are due to primary abnormalities in the DMD gene causing the almost-complete absence of the cytoskeletal Dp427-M isoform of dystrophin in voluntary muscles, the excessive accumulation of extracellular matrix proteins presents a key histopathological hallmark of muscular dystrophy. Animal model research has been instrumental in the characterization of dystrophic muscles and has contributed to a better understanding of the complex pathogenesis of dystrophinopathies, the discovery of new disease biomarkers, and the testing of novel therapeutic strategies. In this article, we review how mass-spectrometry-based proteomics can be used to study changes in key components of the endomysium, perimysium, and epimysium, such as collagens, proteoglycans, matricellular proteins, and adhesion receptors. The mdx-4cv mouse diaphragm displays severe myofibrosis, making it an ideal model system for large-scale surveys of systematic alterations in the matrisome of dystrophic fibers. Novel biomarkers of myofibrosis can now be tested for their appropriateness in the preclinical and clinical setting as diagnostic, pharmacodynamic, prognostic, and/or therapeutic monitoring indicators. |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
650 | _ | 7 | |a biglycan |2 Other |
650 | _ | 7 | |a collagen |2 Other |
650 | _ | 7 | |a dystrophin |2 Other |
650 | _ | 7 | |a dystrophinopathy |2 Other |
650 | _ | 7 | |a extracellular matrix |2 Other |
650 | _ | 7 | |a fibronectin |2 Other |
650 | _ | 7 | |a fibrosis |2 Other |
650 | _ | 7 | |a matrisome |2 Other |
650 | _ | 7 | |a mdx |2 Other |
650 | _ | 7 | |a periostin |2 Other |
650 | _ | 7 | |a Extracellular Matrix Proteins |2 NLM Chemicals |
650 | _ | 7 | |a Biomarkers |2 NLM Chemicals |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a Mice |2 MeSH |
650 | _ | 2 | |a Mice, Inbred mdx |2 MeSH |
650 | _ | 2 | |a Diaphragm: metabolism |2 MeSH |
650 | _ | 2 | |a Diaphragm: pathology |2 MeSH |
650 | _ | 2 | |a Proteomics |2 MeSH |
650 | _ | 2 | |a Muscular Dystrophy, Duchenne: pathology |2 MeSH |
650 | _ | 2 | |a Muscle, Skeletal: metabolism |2 MeSH |
650 | _ | 2 | |a Extracellular Matrix: metabolism |2 MeSH |
650 | _ | 2 | |a Extracellular Matrix Proteins: genetics |2 MeSH |
650 | _ | 2 | |a Extracellular Matrix Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Biomarkers: metabolism |2 MeSH |
700 | 1 | _ | |a Gargan, Stephen |b 1 |
700 | 1 | _ | |a Zweyer, Margit |0 P:(DE-2719)9000835 |b 2 |u dzne |
700 | 1 | _ | |a Swandulla, Dieter |0 0000-0003-0923-7090 |b 3 |
700 | 1 | _ | |a Ohlendieck, Kay |0 0000-0002-6266-4510 |b 4 |
770 | _ | _ | |a Muscular Dystrophy: From Molecular Basis to Therapies |
773 | _ | _ | |a 10.3390/biom13071108 |g Vol. 13, no. 7, p. 1108 - |0 PERI:(DE-600)2701262-1 |n 7 |p 1108 |t Biomolecules |v 13 |y 2023 |x 2218-273X |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/259687/files/DZNE-2023-00759.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/259687/files/DZNE-2023-00759.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:259687 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)9000835 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-22 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-22 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-22 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-22 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-22 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-04-12T14:57:05Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-04-12T14:57:05Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-04-12T14:57:05Z |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BIOMOLECULES : 2022 |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-26 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-26 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-26 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b BIOMOLECULES : 2022 |d 2023-10-26 |
920 | 1 | _ | |0 I:(DE-2719)5000032 |k AG Sabir |l Neonatal Neuroscience |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)5000032 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|